Open Insulin, 'DIY bio' and the future of pharma
The status quo of the U.S. pharmaceutical market may soon be turned on its head, according to CSU scientists.
The status quo of the U.S. pharmaceutical market may soon be turned on its head, according to CSU scientists.
A CSU researcher is taking a closer look at a chemical that seems to be critical to the dilation of blood vessels and oxygen delivery in the body — and it could prove to be a game-changer for older adults, diabetics and others with circulation problems.
At the Women of Vision Gala in July, two CSU students were awarded the Joan C. King-Tobet Memorial Scholarship for exceptional students with an interest in biomedical science or biomedical engineering.
Twenty-four students recently traveled to Ecuador as part of the Range of Motion Project. The experience helped them see how their training can prepare them for careers helping individuals with limb loss.
In May, the School of Biomedical Engineering led a study abroad course in Quito, Ecuador to work with Range of Motion Project volunteers and learn how to build and fit prostheses for patients.
Kimmey is applying his engineering education to real-world medical problems, working with the Range of Motion Project in Ecuador and for Medtronic this summer.
The Munsky group of the Department of Chemical and Biological Engineering and their collaborators at Vanderbilt University recently published new advances to predictive biological models for gene regulation in the Proceedings of the National Academy of Sciences.
Synthetic biologists are attempting to manufacture sporopollenin in the lab using plants, and to control its properties using gene circuits.
Synthetic biologists are attempting to manufacture sporopollenin in the lab using plants, and to control its properties using gene circuits.
Wilson is proposing a radical new imaging technology that could diagnose mitochondrial defects in an instant.